Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Faron Pharmaceuticals Oy | Helsinki | Healthcare | Biotechnology & Medical Research | €245.48M | -5.1x | -1.35 | €2.36 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17.6% Upside | Upgrade to Pro+ | |
Nightingale Health Oyj | Helsinki | Healthcare | Biotechnology & Medical Research | €169.56M | -10.3x | -2.83 | €2.76 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.2% Upside | Upgrade to Pro+ | |
Solar Foods Oyj | Helsinki | Healthcare | Biotechnology & Medical Research | €113.35M | €4.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Nanoform Finland Plc | Helsinki | Healthcare | Biotechnology & Medical Research | €109.65M | -4.9x | 1.63 | €1.22 | -4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Herantis Pharma Oyj | Helsinki | Healthcare | Biotechnology & Medical Research | €33.06M | -49.7x | -0.59 | €1.64 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.1% Upside | Upgrade to Pro+ |